Abstract:Objective: To study the effect of plumbagin on epithelial-mesenchymal transition (EMT) and underlying mechanisms in human tongue squamous cell carcinoma (TSCC) cells. Methods: Methyl thiazolyl tetrazolium assay was apllied to examine the proliferation inhibition effect and half maximal inhibitory concentration (IC(50)) of plumbagin (0.1, 1.0, 5.0, 10.0, 20.0 μmol/L) in 12, 24, 48 h in TSCC cells. Transwell assay was used to count the number of transmembrane cells and scratch test was performed to examine cells mobility. The flow cytometry was applied to measure intracellular reactive oxygen species (ROS) level in control group, plumbagin group (1.0 μmol/L, 24 h) and glutathione (GSH)+plumbagin group. The expression of E-cadherin, vimentin, Slug, p38 mitogen activated protein kinases (p38MAPK) and phospho-p38MAPK (p-p38MAPK) proteins were determined by Western blotting. The expression of E-cadherin, vimentin and Slug were detected by Western blotting in control group, plumbagin group, activator combined group (p38MAPK activator+plumbagin) and inhibitor combined group (p38MAPK inhibitor+plumbagin). Results: After the treatment of plumbagin for 12, 24, and 48 h, the IC(50) of TSCC cells were 10.3, 3.1, 1.5 μmol/L. After treated by 1.0 μmol/L plumbagin for 24 h, the number of transmembrane cells were significantly reduced ([50±13], P<0.05) in comparison to control group (204±6), as well as the cells mobility ([18.2±2.3]%, P<0.05) in comparison to control group ([49.3±1.2]%). Compared to control group (2.32±0.52), the ROS level was increased in plumbagin group (902.20±10.69), while compared to plumbagin group, the ROS level was reduced in GSH combined group (2.18±0.15). In comparison to control group, the expression of E-cadherin was up-regulated (P<0.05), and vimentin, Slug, p-p38MAPK/p38MAPK were down-regulated in plumbagin group (P<0.05). In comparison to plumbagin group, the expression of E-cadherin was down-regulated (P<0.05), and vimentin, Slug, p-p38MAPK/p38MAPK were up-regulated in GSH combined group (P<0.05). Treatment of cells with p38MAPK activator could decrease the expression of E-cadherin significantly (P<0.05) and increase the expression of vimentin (P<0.05) and Slug (P<0.05) in comparison to plumbagin group. Treatment of cells with p38MAPK inhibitor could increase the expression of E-cadherin significantly (P<0.05) and decrease the expression of vimentin (P<0.05) and Slug (P<0.05) in comparison to plumbagin group. Conclusions: Plumbagin inhibits EMT via ROS/p38MAPK-mediated pathway in human TSCC cells.

Plumbagin Suppresses Epithelial to Mesenchymal Transition and Stemness Via Inhibiting Nrf2-mediated Signaling Pathway in Human Tongue Squamous Cell Carcinoma Cells.

Plumbagin Induces G 2 /M Arrest, Apoptosis, and Autophagy Via P38 MaPK- and Pi3K/akt/mTOr-mediated Pathways in Human Tongue Squamous Cell Carcinoma Cells

Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.

Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma.

Plumbagin Has an Inhibitory Effect on the Growth of TSCC PDX Model and It Enhances the Anticancer Efficacy of Cisplatin.

Cytotoxicity Mechanisms of Plumbagin in Drug-Resistant Tongue Squamous Cell Carcinoma.

[Effect of Plumbagin on Epithelial-Mesenchymal Transition and Underlying Mechanisms in Human Tongue Squamous Cell Carcinoma Cells].

Plumbagin-mediating GLUT1 Suppresses the Growth of Human Tongue Squamous Cell Carcinoma.

Plumbagin Enhances the Radiosensitivity of Tongue Squamous Cell Carcinoma Cells Via Downregulating ATM

Plumbagin Enhances the Anticancer Effects of PF Chemotherapy Via Downregulation of the PI3K/AKT/mTOR/p70S6K Pathway in Human Tongue Squamous Cell Carcinoma.

Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells

Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances

Plumbagin Exhibits Genotoxicity and Induces G2/M Cell Cycle Arrest via ROS-Mediated Oxidative Stress and Activation of ATM-p53 Signaling Pathway in Hepatocellular Cells

Plumbagin Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR-mediated Pathway in Human Pancreatic Cancer Cells

Plumbagin Induces the Apoptosis of Human Tongue Carcinoma Cells Through the Mitochondria-Mediated Pathway

Plumbagin induces g 2 / M arrest , apoptosis , and autophagy via p 38 MaPK-and Pi 3 K / akt / mTOr-mediated pathways in human tongue squamous cell carcinoma cells

Telocinobufagin, a PLK1 suppressor that inhibits tumor growth and metastasis by modulating CDC25c and CTCF in HNSCC cells

Plumbagin Inhibits the Proliferation of Nasopharyngeal Carcinoma 6-10B Cells by Upregulation of Reactive Oxygen Species

Synthetic Isoliquiritigenin Inhibits Human Tongue Squamous Carcinoma Cells through Its Antioxidant Mechanism

Targeting Thioredoxin Reductase By Plumbagin Contributes To Inducing Apoptosis Of Hl-60 Cells

Cucurbitacin B Inhibits Cell Proliferation by Regulating X-Inactive Specific Transcript Expression in Tongue Cancer